NASDAQ:PHIOW - Nasdaq -
We assign a technical rating of 0 out of 10 to PHIOW. PHIOW scores bad on all fronts: it is a bad performer in the overall market and both the medium and short term pictures are negative.
Although the technical rating is bad, PHIOW does present a nice setup opportunity. Prices have been consolidating lately. There is very little resistance above the current price. We notice that large players showed an interest for PHIOW in the last couple of days, which is a good sign.
0.02
Phio Pharmaceuticals Corporation
NASDAQ:PHIOW (12/21/2021, 8:47:54 PM)
0.0232
+0.01 (+36.47%)